|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Janus Pharmaceuticals, Inc. Announces Development and Distribution Agreement with Nihon Nohyaku Co Ltd. for Luliconazole in North America, Europe and South America
4/2/2007 12:16:29 PM
PASADENA, Calif.--(BUSINESS WIRE)--Janus Pharmaceuticals Inc. (Janus), a company focused on the discovery and development of drugs to treat a variety of topical diseases, announced today the execution of license agreement with Nihon Nohyaku Co., Ltd.(NNC) (Tokyo, Japan), an agrochemical and pharmaceutical manufacturer, granting Janus for an exclusive development and sales of a novel antifungal drug “Luliconazole” in North America, Europe and South America.
|
|
|
|
|
|
|
|
|
|
|